May 01, 2019
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.22 to $0.01.
The split itself did not change the total investment value.
Altamira Therapeutics Ltd. (EARS) trades on the NASDAQ Capital Market in the Biotechnology industry.
Altamira Therapeutics Ltd. company overviewThe latest split shown was on May 1, 2019. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between March 14, 2018 and May 1, 2019.
Already premium? Sign in